Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients

Hepatitis B virus (HBV) reactivation has been noted in HBV surface antigen (HBsAg)-seronegative patients with CD20(+) B-cell non-Hodgkin lymphoma (NHL) undergoing rituximab treatment. Clinically, hepatitis flares are usually associated with the reappearance of HBsAg (reverse seroconversion of HBsAg,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Liang-Tsai, Wang, Hao-Yuan, Yang, Ching-Fen, Chiou, Tzeon-Jye, Gau, Jyh-Pyng, Yu, Yuan-Bin, Liu, Hsiao-Ling, Chang, Wen-Chun, Chen, Po-Min, Tzeng, Cheng-Hwai, Chan, Yu-Jiun, Yang, Muh-Hwa, Liu, Jin-Hwang, Huang, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839912/
https://www.ncbi.nlm.nih.gov/pubmed/26986131
http://dx.doi.org/10.1097/MD.0000000000003064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839912/
https://www.ncbi.nlm.nih.gov/pubmed/26986131
http://dx.doi.org/10.1097/MD.0000000000003064

Ejemplares similares